What You Need To Know Ahead of Boston Scientific's Earnings Release

With a market cap of $144.2 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets innovative medical devices used in various interventional medical specialties worldwide. It operates through two main segments: MedSurg and Cardiovascular, offering advanced solutions for diagnosing and treating complex conditions across gastrointestinal, urological, neurological, and cardiovascular care. The Marlborough, Massachusetts-based company is slated to announce its fiscal Q3 2025 earnings ...